Skip to main content
. 2017 May 17;11(3):119–133. doi: 10.1177/2049463717710042

Figure 2.

Figure 2.

CONSORT flow diagram for study 1.

ITT: intention-to-treat.

*Two patients in the Sativex group did not administer any IMP, so although these patients were included in the patient demographic data, they were excluded from the efficacy and safety analysis sets.